Note: Ingredients listed on restricted chemical lists
General Information
Product name
Idarubicin Hydrochloride Injection, USP
Chemical name
(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3- amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside, hydrochloride
supplier name
West-Ward Pharmaceuticals Corp
Manufacturer Name
THYMOORGAN PHARMAZIE GmbH
Icons in SDS
Company Information
company name
West-Ward Pharmaceuticals Corp
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200).
2.1 Classification of the substance or mixture
CARCINOGENICITY - Category 2 TOXIC TO REPRODUCTION (Fertility) - Category 1B TOXIC TO REPRODUCTION (Unborn child) - Category 1B
Signal word
Danger
Hazard statements
H360 - May damage fertility or the unborn child. H351 - Suspected of causing cancer. This is a pharmaceutical product designed to be prescribed by a licensed health care professional. Should any person while using this product observe any adverse health effects, they should seek medical treatment.
Prevention
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves. Wear eye or face protection. Wear protective clothing.
Response
P308 + P313 - IF exposed or concerned: Get medical attention.
Storage
P405 - Store locked up.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
2.3 Other hazards
None known.
